Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial von Coleman, Robert L., Handley, Katelyn F., Burger, Robert, Molin, Graziela Zibetti Dal, Stagg, Robert, Sood, Anil K., Moore, Kathleen N.

Volltext

First report of hepatic hematoma after presumed Bothrops envenomation von Cunha, Fernanda Cristina, Heerdt, Maike, Torrez, Pasesa Pascuala Quispe, França, Francisco Oscar de Siqueira, Molin, Graziela Zibetti Dal, Battisti, Rúbia, Zannin, Marlene

Volltext

A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or... von Chelariu-Raicu, Anca, Nick, Alpa, Urban, Renata, Gordinier, Mary, Leuschner, Carola, Bavisotto, Linda, Molin, Graziela Zibetti Dal, Whisnant, John K., Coleman, Robert L.

Volltext

Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Ca... von Maluf, Fernando Cotait, Dal Molin, Graziela Zibetti, de Melo, Andreia Cristina, Paulino, Eduardo, Racy, Douglas, Ferrigno, Robson, Uson Junior, Pedro Luiz Serrano, Ribeiro, Reitan, Moretti, Renato, Sadalla, Jose Carlos, Nogueira-Rodrigues, Angelica, Carvalho, Filomena Marino, Baiocchi, Glauco, Callegaro-Filho, Donato, Abu-Rustum, Nadeem R.

Volltext

Recommendations for the treatment of vulvar cancer in settings with limited resources: Report from the International Gynecological Cancer Society consensus meeting von Maluf, Fernando Cotait, Zibetti, Graziela Dal Molin, Paulino, Eduardo, de Melo, Andreia Cristina, Racy, Douglas, Ferrigno, Robson, Uson Junior, Pedro Luiz Serrano, Ribeiro, Reitan, Moretti, Renato, Sadalla, Jose Carlos, Nogueira Rodrigues, Angelica, Carvalho, Filomena Marino, Baiocchi, Glauco, Callegaro-Filho, Donato, Angioli, Roberto

Volltext

Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma von Stur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y, Mangala, Lingegowda S, Yao, Hui, Wang, Ying, Ram, Prahlad T, Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S, Levine, Douglas A, Lutgendorf, Susan K, Liu, Jinsong, Moore, Kathleen N, Baggerly, Keith A, Karlan, Beth Y, Sood, Anil K

Volltext

Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic von Freitas, Helano C., Torrezan, Giovana Tardin, Cunha, Isabela Werneck da, Macedo, Mariana Petaccia, Karen de Sá, Vanessa, Corassa, Marcelo, Ferreira, Elisa Napolitano e, Saito, Augusto Obuti, Dal Molin, Graziela Zibetti, Cordeiro de Lima, Vladmir C., Carraro, Dirce Maria

Volltext

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma von Zibetti Dal Molin, Graziela, Abrahão, Carina Meira, Coleman, Robert L, Maluf, Fernando Cotait

Volltext

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study von Pant, Shubham, Schuler, Martin, Iyer, Gopa, Witt, Olaf, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Lugowska, Iwona, Carranza, Omar, Arnold, Dirk, Gutierrez, Martin, Winter, Helen, Stuyckens, Kim, Crow, Lauren, Najmi, Saltanat, Thomas, Shibu, Santiago-Walker, Ademi, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann, Carranza, Omar, Coward, Jim, Joshua, Anthony, Karapetis, Christos, Hart, Christopher, Zhang, Alison, Prenen, Hans, Goeminne, Jean-Charles, Machiels, Jean-Pascal, Rottey, Sylvie, Corassa, Marcelo, Molin, Graziela Zibetti Dal, Tiscoski, Katsuki, Mak, Milena, Fu, Wei, Yao, Herui, Jiang, Haiping, Qin, Shukui, Chen, Baoshi, Yang, Yu, Loriot, Yohann, Le Tourneau, Christophe, Penel, Nicolas, Durando, Xavier, Emambux, Sheik, Folprecht, Gunnar, Arnold, Dirk, Schuler, Martin, Ahrens, Marit, Golf, Alexander, Haag, Georg Martin, Desuki, Alexander, Cazzaniga, Marina, Ciardiello, Fortunato, Koyama, Takafumi, Aogi, Kenjiro, Kuboki, Yasutoshi, Lee, Jungyun, Kim, Sung-Bae, Chang, Jong Hee, Kim, Yong-Man, Nam, Do-Hyun, Park, Jae-Sung, Lugowska, Iwona, Paz-Ares, Luis, Moreno, Victor, Calvo, Mariona, Falcon, Alejandro, Gonzalez, Antonio, Tabernero, Josep, Martinez Bueno, Alejandro, García-Corbacho, Javier, Chen, Jen-Shi, Hou, Ming-Feng, Chao, Yee, Rau, Kun-Ming, Chiu, Tai-Jan, Feng, Yin-Hsun, Hsu, Chih-Hung, Lai, Kuan-Ming, Yeh, Su-peng, Minchom, Anna, Welsh, Liam, Plummer, Ruth, Gutierrez, Martin, Arrowsmith, Edward, Pant, Shubham, Spigel, David Robert, Zandberg, Dan Paul, Doroshow, Deborah, Moezi, Mehdi, Paulson, Scott, Reardon, David, Ward, Patrick, Chaves, Jorge, Hussein, Atif, Manda, Sudhir, Richey, Stephen L, Tamura, David, Wilks, Sharon

Volltext

Frailty repels the knife: the impact of frailty index on surgical intervention and outcomes von Handley, Katelyn, Sood, Anil, Dal Molin, Graziela Zibetti, Westin, Shannon, Meyer, Larissa, Fellman, Bryan, Soliman, Pamela, Fleming, Nicole

Volltext

A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopi... von Damian, Fernanda Bronzon, Melo, Andreia Cristina De, Zibetti Dal Molin, Graziela, Rodrigues, Angelica Nogueira, Calabrich, Aknar Freire de Carvalho, Werutsky, Gustavo, Filho, Elias Abdo, Rebelatto, Taiane Francieli, de Jesus, Rafaela Gomes, Jimenez, Mirela Foresti

Volltext

Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer? von Batista, Thales Paulo, Dal Molin, Graziela Zibetti

Volltext

Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes von Handley, Katelyn F., Sood, Anil K., Molin, Graziela Zibetti Dal, Westin, Shannon N., Meyer, Larissa A., Fellman, Bryan, Soliman, Pamela T., Coleman, Robert L., Fleming, Nicole D.

Volltext

Abstract A26: Molecular analysis of short- vs. long-term ovarian cancer survivors von Stur, Elaine, Dal Molin, Graziela Zibetti, Wu, Sherry, Baggerly, Keith, Tworoger, Shelley, Levine, Douglas, Karlan, Beth, Moore, Kathleen, Lutgendorf, Susan, Sood, Anil

Volltext

Efficacy and safety of erdafitinib in adults with cholangiocarcinoma (CCA) with prespecified fibroblast growth factor receptor alterations ( FGFRalt ) in the phase 2 open-label, si... von Pant, Shubham, Schuler, Martin H., Iyer, Gopa, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Arnold, Dirk, Gutierrez, Martin, Prenen, Hans, Folprecht, Gunnar, Winter, Helen, Cosman, Rasha, Zibetti Dal Molin, Graziela, Xia, Qi, Najmi, Saltanat, Hammond, Constance, Thomas, Shibu, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann

Volltext

Prospective assessment of hypercalcemia of malignancy and infectious complications von Tavares, Monique Celeste, Dal Molin, Graziela Zibetti, Felismino, Tiago Cordeiro, Fanelli, Marcello Ferretti, Freitas, Helano C., Barros e Silva, Milton Jose

Volltext

Number of sites of metastasis (NSM) and progression-free survival (PFS) in patients (PTS) with melanoma treated with ipilimumab (IPI) von Tavares, Monique Celeste, De Barros E. Silva, Milton Jose, Rinck, Jose A., Urvanegia, Ana Claudia Machado, Macedo, Mariana Petaccia, Pinto, Clovis, Bezerra, Tiago, Dal Molin, Graziela Zibetti, Santos, Fábio Nasser, Yamamura, Rosely, Lima, Geraldine Eltz, Fanelli, Marcello Ferretti

Volltext

First report of hepatic hematoma after presumed Bothrops envenomation von Fernanda, Cristina Cunha, Heerdt, Maike, Pasesa, Pascuala Quispe Torrez, Francisco, Oscar despaceSiqueira França, Graziela, Zibetti Dal Molin, Battisti, Rúbia, Zannin, Marlene

Volltext

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma von Zibetti Dal Molin, Graziela, Abrahão, Carina Meira, Coleman, Robert L, Maluf, Fernando Cotait

Volltext